Analysis By Product & Services (Assays and Kits, Instruments, and Services and Software), Technology (PCR, Isothermal Nucleic Acid Amplification Technology (INAAT), and Other Technologies), Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, and Other Applications), End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes, and Others)
No. of Pages:166
Report Code:
TIPRE00026191
Category:
Life Sciences
Middle East and Africa Point-of-Care Molecular Diagnostics Market
Point-of-care molecular diagnostics include portable devices, and assays & kits used to detect and diagnose diseases in human samples, such as throat swab, blood, serum, and stool. Molecular diagnostics are shifting from centralized laboratories to decentralized point-of-care molecular testing. Due to its simplicity, convenience, rapid turnaround time, and potential to improve patient outcomes, POCT is rapidly gaining traction.
Moreover, the growing demand for specific viral detection methods that consume less time for timely infection control is expected to bolster the market growth during the forecast period.
South Africa has reported the highest COVID-19 cases in the Middle East and Africa, followed by Saudi Arabia and the UAE, among others. The Saudi government policies have been favoring the proliferation of domestic pharmaceutical manufacturers; the government has lifted import duties on raw materials and intermediate products and made financing easy by supporting interest-free funding. Similarly, the continuously increasing incidence of COVID-19 is creating a huge demand for kits and reagent used in its diagnosis. In April 2020, BGI Group, a Chinese genomics company, and Group-42, a UAE technology company, unveiled a new massive-throughput laboratory in the UAE to support testing and diagnosis of the novel coronavirus. According to the BGI Group, the lab will use RT-PCR diagnostic kits that have been approved by medical regulatory authorities in China, Europe, the US, and Japan. As point-of-care molecular diagnostics kits are majorly used in the detection of SARS-CoV-2, the pandemic is fueling the market growth.
Market Overview and Dynamics
The Middle East & Africa Point-of-Care Molecular Diagnostics market is expected to reach US$ 212.9 million by 2028 from US$ 94.0 million in 2021. The market is estimated to grow at a CAGR of 12.4% from 2021–2028. Point-of-care (POC) molecular tests are accurate and scalable that increase the scope for the diagnosis of diseases, which can be done in the community and outside the laboratory setting. Compared with laboratory testing, point-of-care molecular diagnostics provides various advantages such as fewer clinic visits, shorter hospital stays, better drug therapy optimization, and less inappropriate drug use. The healthcare sector is undergoing huge transformation due to the emergence of new and effective technologies across the sector. Thus, the growing demand for effective diagnostics that consumes less time than laboratory testing drives the demand for POC molecular assays and kits propelling the growth of Middle East & Africa point-of-care molecular diagnostics market over the forecast period.
Key Market Segments
In terms of product & services, the assays and kits segment accounted for the largest share of the Middle East & Africa Point-of-Care Molecular Diagnostics market in 2020. In terms of technology, the PCR segment accounted for the largest share of the Middle East & Africa Point-of-Care Molecular Diagnostics market in 2020. In terms of application, the infectious diseases segment accounted for the largest share of the Middle East & Africa Point-of-Care Molecular Diagnostics market in 2020. In terms of end user, the diagnostic laboratories segment accounted for the largest share of the Middle East & Africa Point-of-Care Molecular Diagnostics market in 2020.
Major Sources and Companies Listed
A few major primary and secondary sources referred to for preparing this report on the Point-of-Care Molecular Diagnostics market in Middle East & Africa are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are bioMérieux SA, F. Hoffmann-La Roche Ltd., Danaher Corporation, Enzo Biochem, Inc., Abbott, Meridian BioScience, Inc., Biocartis, Quidel Corporation, and Bio-Rad Laboratories, Inc.
Reasons to Buy Report
To understand the Middle East & Africa Point-of-Care Molecular Diagnostics market landscape and identify market segments that are likely to guarantee a strong return
To comprehend the ever-changing market landscape and stay ahead in competition
To efficiently plan merger and acquisition, and partnership deals in the Middle East & Africa Point-of-Care Molecular Diagnostics market by identifying segments with the most promising probable sales
To make knowledgeable business decisions from perceptive and comprehensive analysis of the market performance of various segments
To obtain market revenue forecast of the Middle East & Africa Point-of-Care Molecular Diagnostics market based on various segments for the period 2021–2028
MIDDLE EAST & AFRICA POINT-OF-CARE MOLECULAR DIAGNOSTICS MARKET SEGMENTATION
The List of Companies - Middle East and Africa Point-of-Care Molecular Diagnostics Market
bioMérieux SA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Enzo Biochem, Inc.
Abbott
Meridian BioScience, Inc.
Biocartis
Quidel Corporation
Bio-Rad Laboratories, Inc.
Frequently Asked Questions
How big is the Middle East and Africa Point-of-Care Molecular Diagnostics Market?
The Middle East and Africa Point-of-Care Molecular Diagnostics Market is valued at US$ 94.0 Million in 2021, it is projected to reach US$ 212.9 Million by 2028.
What is the CAGR for Middle East and Africa Point-of-Care Molecular Diagnostics Market by (2021 - 2028)?
As per our report Middle East and Africa Point-of-Care Molecular Diagnostics Market, the market size is valued at US$ 94.0 Million in 2021, projecting it to reach US$ 212.9 Million by 2028. This translates to a CAGR of approximately 12.4% during the forecast period.
What segments are covered in this report?
The Middle East and Africa Point-of-Care Molecular Diagnostics Market report typically cover these key segments-
Product & Services (Assays and Kits, Instruments, Services and Software)
Technology (PCR, Isothermal Nucleic Acid Amplification Technology, Other Technologies)
Application (Infectious Diseases, Oncology, Hematology, Prenatal Testing, Endocrinology, Other Applications)
End User (Hospitals and Clinics, Diagnostic Laboratories, Research and Academic Institutes)
What is the historic period, base year, and forecast period taken for Middle East and Africa Point-of-Care Molecular Diagnostics Market?
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Middle East and Africa Point-of-Care Molecular Diagnostics Market report:
Historic Period : 2019-2020
Base Year : 2021
Forecast Period : 2022-2028
Who are the major players in Middle East and Africa Point-of-Care Molecular Diagnostics Market?
The Middle East and Africa Point-of-Care Molecular Diagnostics Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
bioMérieux SA
F. Hoffmann-La Roche Ltd.
Danaher Corporation
Enzo Biochem, Inc.
Abbott
Meridian BioScience, Inc.
Biocartis
Quidel Corporation
Bio-Rad Laboratories, Inc.
Who should buy this report?
The Middle East and Africa Point-of-Care Molecular Diagnostics Market report is valuable for diverse stakeholders, including:
Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.
Essentially, anyone involved in or considering involvement in the Middle East and Africa Point-of-Care Molecular Diagnostics Market value chain can benefit from the information contained in a comprehensive market report.
Get Free Sample For Middle East and Africa Point-of-Care Molecular Diagnostics Market
